. poll: can technology solve irish border issue after brexit?
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
mayo clinic: "migraine: diagnosis & treatment," "monoclonal antibody drugs for cancer: how they work."
.
. 7 eco-friendly alternatives to plastic straws to help save the oceans
.